Report in the Independent on the Diabetes drug Actos/Competact (active ingredient Piolitazone) with people showing an 88% increased risk of bladder cancer! That’s pretty high.
Independent 1.6.12 “DIABETES DRUG INCREASES CANCER RISK”
People prescribed Actos (piolitazone) for type-2 diabetes were found to increase the risk of bladder cancer by 83%. Montreal researchers studied NHS records of 115,727 people. Those prescribed it for over 2 years were at an 88% increased risk.
Dr David Juurlink, head of Clinical Pharmacology at Toronto Uni, said he thinks this is the single best study, which leaves little doubt that piolitazone is a potential risk factor for bladder cancer.
Research at McGill University & Montreal’s Jewish General Hospital. Published in ‘British Medical Journal’ on 31.5.12.
Piolitazone can be given with the drug Metformin for controlling blood sugar. See my recent post on Metformin here too.